Understanding frailty in older adults with polymyalgia rheumatica
Prevalence and Impact of frailty in older adults with polymyalgia rheumatica
This study is looking at how being frail affects older adults with polymyalgia rheumatica, focusing on how therapy can help improve their symptoms and overall well-being.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10976128 on NIH RePORTER |
What this research studies
This research investigates the prevalence and impact of frailty in older adults suffering from polymyalgia rheumatica (PMR), a common systemic rheumatic disease. It aims to identify how frailty affects symptoms and treatment duration, particularly focusing on the role of physical and occupational therapy in improving patient outcomes. By exploring the relationship between frailty and persistent symptoms, the study seeks to develop tailored interventions that could enhance the well-being of this vulnerable population. The research will also examine factors influencing access to therapy and its effects on medication use.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults diagnosed with polymyalgia rheumatica, particularly those experiencing persistent symptoms.
Not a fit: Patients who are younger or do not have a diagnosis of polymyalgia rheumatica may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better quality of life for older adults with polymyalgia rheumatica.
How similar studies have performed: Previous research has shown that physical activity interventions can significantly improve symptoms in older adults with chronic musculoskeletal conditions, suggesting a promising avenue for this study.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Sattui, Sebastian Eduardo — University of Pittsburgh at Pittsburgh
- Study coordinator: Sattui, Sebastian Eduardo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.